MILE STONES

2003

Acquired API facility at Jaggaiahpet

2004

Upgraded the API facility to GMP standards

2005

API facility was made FDA compliant
. Entered Formulation Business

2006

Started Clinical Research and Biosciences
.Acquired formulation at Balanagar

2007

USFDA approval for API plant

2008

Obtained MHRA approval for CRBio (Project-based)

2009

.MOH Turkey approval for CRBio
.Japanese approval for API

2010

Expansion of API facility

2011

Expansion of CRBio facility

2012

USFDA Approval for API and CRBio facilities

2013

.USFDA Approval for Formulation facility
.EDQM Approval for API facility

2014

.Formulation Facility audited and cleared by COFEPRIS, MHRA & USFDA

2015

.API Facility Audited by COFEPRIS & EDQM
.API R&D facility was recognized by Department of Science and Industrial Research (DSIR), a government of India authority.

2016

Formulations R&D was recognized by Department of Science and Industrial Research (DSIR), a government of India authority.